Nyxoah SA (NYXH) Stock Forecast: StockMap's 2-Week Call
NYXH stock forecast: StockMap's model calls Nyxoah SA Strong Underperform for the two weeks after the Nov 19 close: it expects NYXH to trail the growth index. It is a call on the gap, not a price target. Right in 3 of 6 two-week windows on NYXH since Aug 21; by chance, a call on the same dates was right 59% of the time.
Nyxoah SA last closed at $0.86, +0.00% on the session.
Against the IVW growth benchmark the position is +2.33% over the forecast window.
Nyxoah SA's market cap is $87.89M as of November 19, 2026.
Calls down ↘: the model's call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -60 (behind).
Where NYXH sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 0 bullish and 15 bearish.
Agreement across those insights is 100%.
49 daily calls for NYXH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Nyxoah SA in the 6th percentile on return on equity, where 100 is best.
Nyxoah SA is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Nyxoah SA as the 105th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Nyxoah SA ranks 132nd of 141 in the group, against a group median of -0.18.